Fig. 7
From: Renal function in β-thalassemia major patients treated with two different iron-chelation regimes
Correlations between urinary Ca/Cr ratio (A) in All patients group (r = − 0.35, p = 0.03), in DFX group (r = − 0.35, p = 0.03) and in the DFO+/−DFP group showing a significant negative correlation (r = − 0.68, p = 0.03). Correlation between urinary Ca/Cr ratio and amount of iron transfused over the prior10 years in (B) all patients group (r = − 0.4 p = 0.014), in DFX group (r = − 0.12, p = 0.5) and DFO+/−DFP group showing a significant negative correlation (r = − 0.55 p = 0.09). (DFX) Deferasirox. (DFO) Desferrioxamine. (DFP) Deferiprone